Talphera (TLPH) Retained Earnings (2010 - 2026)

Talphera's (TLPH) quarterly Retained Earnings came in at $492.5 million in Q1 2026, up 207.11% year-on-year from $160.4 million in Q1 2025, and up 0.82% quarter-over-quarter from $488.5 million in Q4 2025.

Talphera (TLPH) Retained Earnings (2010 - 2026) Analysis & Trends

Talphera's Retained Earnings history runs 17 years deep, the most recent figure standing at $492.5 million for Q1 2026.

  • On a quarterly basis, Retained Earnings rose 207.11% year-over-year to $492.5 million in Q1 2026; TTM through Mar 2026 was $492.5 million, a 207.11% increase from a year earlier, with the FY2025 full-year figure at $488.5 million, up 206.84% from the prior year.
  • Retained Earnings rose to $492.5 million in Q1 2026 per TLPH's latest filing, from $488.5 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $492.5 million in Q1 2026 and bottomed at -$482.3 million in Q1 2022.
  • The 5-year median for Retained Earnings is $448.2 million (2023), against an average of $91.0 million.
  • Across the five-year window, Retained Earnings slumped 214.82% in 2022 and jumped 207.63% in 2023, its largest moves.
  • Year by year, Retained Earnings stood at -$425.8 million in 2022, then soared by 207.63% to $458.3 million in 2023, then plunged by 199.76% to -$457.2 million in 2024, then jumped by 206.84% to $488.5 million in 2025, then gained by 0.82% to $492.5 million in 2026.
  • Per Business Quant, the three latest TLPH Retained Earnings figures stand at $492.5 million (Q1 2026), $488.5 million (Q4 2025), and $486.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 37.04 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 28.20 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 1.11 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 4.54 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 8.83 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -1.81 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 18.66 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 589.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -2.13 Bn
10 Talphera 47.31 Mn 9.48 Mn - 492.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 492.50 Mn
Dec 31, 2025 488.51 Mn
Sep 30, 2025 486.88 Mn
Jun 30, 2025 469.92 Mn
Mar 31, 2025 -459.82 Mn
Dec 31, 2024 -457.23 Mn
Sep 30, 2024 -455.36 Mn
Jun 30, 2024 464.72 Mn
Mar 31, 2024 464.50 Mn
Dec 31, 2023 458.31 Mn
Sep 30, 2023 458.00 Mn
Jun 30, 2023 -438.35 Mn
Mar 31, 2023 448.21 Mn
Dec 31, 2022 -425.83 Mn
Sep 30, 2022 445.56 Mn
Jun 30, 2022 -411.60 Mn
Mar 31, 2022 -482.26 Mn
Dec 31, 2021 437.68 Mn
Sep 30, 2021 -465.67 Mn
Jun 30, 2021 -457.29 Mn